Are GLP-1s Losing Effect Over Time—or Is It Just a Plateau?
Early rapid weight loss from GLP-1s typically slows, and real-world data suggest this reflects a physiological plateau rather than true pharmacologic tolerance; long-term data are sparse, so clinicians emphasize dose accuracy, lifestyle reassessment, and tailoring therapy, with consideration of sequencing and alternative options for maintenance.